Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Elewaut

Showing results (91-100 of 299) with videos related to

Pageof 30
Sort By:
Rheumatology International|July 25, 2012
Quantification of IFNγ- and IL17-producing cells after stimulation with citrullinated proteins in healthy subjects and RA patientsKatleen Van Steendam, Marlies De Ceuleneer, Kelly Tilleman, et al.
Rheumatology (Oxford, England)|October 6, 2022
Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trialSimon Krabbe, Thomas Renson, Lennart Jans, et al.
Journal of the American Chemical Society|June 26, 2009
6'-derivatised alpha-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in miceMatthias Trappeniers, Katrien Van Beneden, Tine Decruy, et al.
Rheumatology (Oxford, England)|January 20, 2021
TNFi-induced sustained clinical remission in peripheral spondyloarthritis patients cannot be maintained with a step-down strategy based on methotrexatePhilippe Carron, Ann-Sophie De Craemer, Thomas Renson, et al.
Annals of the Rheumatic Diseases|December 10, 2016
Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis: a proof-of-concept studyRuth Wittoek, Philippe Carron, Bieke Lambert, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 25, 2014
Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international surveyDésirée van der Heijde, Joachim Sieper, Dirk Elewaut, et al.
Molecular Immunology|December 21, 2004
Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiationAnn Sophie Franki, Katrien Van Beneden, Pieter Dewint, et al.
Arthritis and Rheumatism|October 31, 2009
Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblastsValerie Gossye, Dirk Elewaut, Nadia Bougarne, et al.
Plos One|November 29, 2016
A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise StudySophie De Mits, Jan Lenaerts, Bert Vander Cruyssen, et al.
Rheumatology International|September 27, 2008
Clinical observations programme in SpA: disease parameters, treatment options and practical management issuesDirk Elewaut, Filip Van den Bosch, Gust Verbruggen, et al.
Pageof 30

Showing results (91-100 of 299) with videos related to

Sort By:
Pageof 30
Rheumatology International|July 25, 2012
Quantification of IFNγ- and IL17-producing cells after stimulation with citrullinated proteins in healthy subjects and RA patientsKatleen Van Steendam, Marlies De Ceuleneer, Kelly Tilleman, et al.
Rheumatology (Oxford, England)|October 6, 2022
Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trialSimon Krabbe, Thomas Renson, Lennart Jans, et al.
Journal of the American Chemical Society|June 26, 2009
6'-derivatised alpha-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in miceMatthias Trappeniers, Katrien Van Beneden, Tine Decruy, et al.
Rheumatology (Oxford, England)|January 20, 2021
TNFi-induced sustained clinical remission in peripheral spondyloarthritis patients cannot be maintained with a step-down strategy based on methotrexatePhilippe Carron, Ann-Sophie De Craemer, Thomas Renson, et al.
Annals of the Rheumatic Diseases|December 10, 2016
Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis: a proof-of-concept studyRuth Wittoek, Philippe Carron, Bieke Lambert, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 25, 2014
Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international surveyDésirée van der Heijde, Joachim Sieper, Dirk Elewaut, et al.
Molecular Immunology|December 21, 2004
Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiationAnn Sophie Franki, Katrien Van Beneden, Pieter Dewint, et al.
Arthritis and Rheumatism|October 31, 2009
Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblastsValerie Gossye, Dirk Elewaut, Nadia Bougarne, et al.
Plos One|November 29, 2016
A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise StudySophie De Mits, Jan Lenaerts, Bert Vander Cruyssen, et al.
Rheumatology International|September 27, 2008
Clinical observations programme in SpA: disease parameters, treatment options and practical management issuesDirk Elewaut, Filip Van den Bosch, Gust Verbruggen, et al.
Pageof 30